相关实验视频
Updated: Jun 23, 2025

05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
1.6K
计算机驱动的配方开发的金色化物Rh2三元固体分散
Tianshu Lu1,2, Tongchuan Wu3, Hao Zhong2
1Institute of Applied Physics and Materials Engineering, University of Macau, Macau, 999078, China.
Drug delivery and translational research
|June 24, 2024
概括
这项研究开发了一种改进的配方 (20S) - 基因化物Rh2,增强其溶解性和生物可用性,以更好地提供抗癌药物. 使用先进的计算和实验方法创建了一个新的固体分散.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 计算化学的计算化学
背景情况:
- (20S) - 丁香精中的强效抗癌素Rh2 - 丁香精具有较差的水溶性和生物可用性,限制了其治疗用途.
- 开发先进的配方是克服这些局限性的关键,并释放金赛诺Rh2在癌症治疗中的全部潜力.
研究的目的:
- 设计一种经过修改的 (20S) - 基因化物Rh2配方,显著提高溶解度,溶解率和生物可用性.
- 利用结合的计算和实验方法优化固体分散配方的开发.
主要方法:
- 利用"PharmSD"模型预测最佳的聚合物固体分散,然后对溶解度和溶解度进行实验性评估.
- 采用粉末X射线衍射 (PXRD),里埃变换红外光谱学 (FTIR) 和分子动力学模拟用于表征和机制阐明.
- 进行了体外细胞和体内动物实验,以评估开发的配方的疗效和吸收.
主要成果:
- 凝44/14被确定为最佳聚合物,其三元固体分散包括二甲基硫酸盐 (SDS),进一步提高溶解速率.
- 鉴定证实了固体分散物中20S-Ginsenoside Rh2的无形状态,在药物和辅助剂之间观察到键相互作用.
- 修改后的配方在细胞研究中显示出较低的排泄比率,并且与纯 (20S) 基因化物Rh2相比,在小鼠体内显著改善了吸收.
结论:
- 成功开发了一种优化的三元固体分散 (20S) -Ginsenoside Rh2具有卓越的溶解性,溶解性和生物可用性.
- 人工智能 (AI) 和分子动力学模拟的整合在指导难溶药物的配方开发方面被证明是有效的.
- 这种方法为增强天然化合物的药物应用提供了一个有前途的策略,比如Ginsenoside Rh2.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
129
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
129
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
295
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
295

